Bendamustine for indolent non-Hodgkin lymphoma in the front-line or relapsed setting: a review of pharmacokinetics and clinical trial outcomes.
about
Bendamustine for indolent non-Hodgkin lymphoma in the front-line or relapsed setting: a review of pharmacokinetics and clinical trial outcomes.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Bendamustine for indolent non- ...... s and clinical trial outcomes.
@en
type
label
Bendamustine for indolent non- ...... s and clinical trial outcomes.
@en
prefLabel
Bendamustine for indolent non- ...... s and clinical trial outcomes.
@en
P2860
P1476
Bendamustine for indolent non- ...... s and clinical trial outcomes.
@en
P2093
Richard van der Jagt
P2860
P304
P356
10.1586/17474086.2013.841538
P577
2013-10-01T00:00:00Z